tiprankstipranks
Trending News
More News >
Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF
US Market

Defence Therapeutics (DTCFF) Ratios

Compare
26 Followers

Defence Therapeutics Ratios

DTCFF's free cash flow for Q1 2026 was C$―. For the 2026 fiscal year, DTCFF's free cash flow was decreased by C$ and operating cash flow was C$―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.84- 0.05 0.05 15.58
Quick Ratio
0.84- 0.05 0.05 15.58
Cash Ratio
0.81- 0.01 0.01 12.67
Solvency Ratio
-1.40- -3.23 -3.23 -3.43
Operating Cash Flow Ratio
-1.20- -1.06 -1.06 -34.73
Short-Term Operating Cash Flow Coverage
-2.26- -2.51 -2.51 0.00
Net Current Asset Value
C$ -411.59K-C$ -3.85MC$ -3.85MC$ 1.47M
Leverage Ratios
Debt-to-Assets Ratio
0.59- 3.66 3.66 0.49
Debt-to-Equity Ratio
-6.34- -0.49 -0.49 1.11
Debt-to-Capital Ratio
1.19- -0.95 -0.95 0.53
Long-Term Debt-to-Capital Ratio
0.00- 0.00 0.00 0.53
Financial Leverage Ratio
-10.76- -0.13 -0.13 2.26
Debt Service Coverage Ratio
-1.73- -6.01 -7.41 -25.05
Interest Coverage Ratio
-7.31- -31.81 0.00 -24.65
Debt to Market Cap
0.03- 0.05 0.05 0.02
Interest Debt Per Share
0.04- 0.05 0.04 0.05
Net Debt to EBITDA
0.22- -0.13 -0.13 0.16
Profitability Margins
Gross Profit Margin
0.00%-0.00%0.00%0.00%
EBIT Margin
0.00%-0.00%0.00%0.00%
EBITDA Margin
0.00%-0.00%0.00%0.00%
Operating Profit Margin
0.00%-0.00%0.00%0.00%
Pretax Profit Margin
0.00%-0.00%0.00%0.00%
Net Profit Margin
0.00%-0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%-0.00%0.00%0.00%
Net Income Per EBT
100.00%-100.00%100.00%98.47%
EBT Per EBIT
112.84%-104.25%104.25%105.97%
Return on Assets (ROA)
-157.04%--2761.51%-2761.51%-191.43%
Return on Equity (ROE)
130.48%-368.09%368.09%-431.80%
Return on Capital Employed (ROCE)
1497.13%-353.87%353.87%-195.66%
Return on Invested Capital (ROIC)
-280.48%-688.65%688.65%-198.65%
Return on Tangible Assets
-157.04%--2761.51%-2761.51%-193.56%
Earnings Yield
-9.20%--40.49%-40.49%-5.84%
Efficiency Ratios
Receivables Turnover
0.00- 0.00 0.00 0.00
Payables Turnover
0.09- 0.04 0.04 0.07
Inventory Turnover
0.00- 0.00 0.00 0.00
Fixed Asset Turnover
0.00- 0.00 0.00 0.00
Asset Turnover
0.00- 0.00 0.00 0.00
Working Capital Turnover Ratio
0.00- 0.00 0.00 0.00
Cash Conversion Cycle
-4.14K- -8.39K -8.39K -5.06K
Days of Sales Outstanding
0.00- 0.00 0.00 0.00
Days of Inventory Outstanding
0.00- 0.00 0.00 0.00
Days of Payables Outstanding
4.14K- 8.39K 8.39K 5.06K
Operating Cycle
0.00- 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.06- -0.10 -0.10 -0.19
Free Cash Flow Per Share
-0.06- -0.10 -0.10 -0.19
CapEx Per Share
<0.01- <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.99- 1.05 1.05 1.01
Dividend Paid and CapEx Coverage Ratio
-183.51- -21.10 -21.10 -116.37
Capital Expenditure Coverage Ratio
-183.51- -21.10 -21.10 -116.37
Operating Cash Flow Coverage Ratio
-2.23- -2.46 -2.46 -4.39
Operating Cash Flow to Sales Ratio
0.00- 0.00 0.00 0.00
Free Cash Flow Yield
-6.89%--13.79%-13.79%-6.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-10.87- -2.47 -2.47 -17.12
Price-to-Sales (P/S) Ratio
0.00- 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
-183.66- -9.09 -9.09 73.94
Price-to-Free Cash Flow (P/FCF) Ratio
-14.51- -7.25 -7.25 -14.99
Price-to-Operating Cash Flow Ratio
-12.98- -7.60 -7.60 -15.12
Price-to-Earnings Growth (PEG) Ratio
-0.94- -0.03 -0.03 1.14
Price-to-Fair Value
-183.66- -9.09 -9.09 73.94
Enterprise Value Multiple
-13.98- -2.70 -2.70 -17.71
Enterprise Value
44.19M- 34.27M 34.27M 114.76M
EV to EBITDA
-13.98- -2.70 -2.70 -17.71
EV to Sales
0.00- 0.00 0.00 0.00
EV to Free Cash Flow
-14.29- -7.63 -7.63 -14.86
EV to Operating Cash Flow
-14.21- -7.99 -7.99 -14.99
Tangible Book Value Per Share
>-0.01- -0.08 -0.08 0.04
Shareholders’ Equity Per Share
>-0.01- -0.08 -0.08 0.04
Tax and Other Ratios
Effective Tax Rate
0.00- 0.00 0.00 -0.02
Revenue Per Share
0.00- 0.00 0.00 0.00
Net Income Per Share
-0.08- -0.30 -0.30 -0.17
Tax Burden
1.00- 1.00 1.00 0.98
Interest Burden
1.14- 1.04 1.04 1.06
Research & Development to Revenue
0.00- 0.00 0.00 0.00
SG&A to Revenue
0.00- 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00- 0.00 0.00 0.00
Income Quality
0.84- 0.33 0.33 1.13
Currency in CAD